Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovation Zed is an Irish medical technology company that specializes in the development of "smart" accessories for insulin pen injectors to improve therapy adherence for patients with diabetes. The company's core technology, the InsulCheck platform, includes clip-on devices that automatically capture injection data, such as time and dosage, and transmit it to digital health applications. These solutions are designed to transform conventional insulin pens into connected devices without requiring patients to switch their preferred injection hardware. In July 2024, Innovation Zed was acquired by SHL Medical, a prominent provider of advanced drug delivery systems, to bolster SHL's digital health and connected device portfolio. The company continues to focus on metabolic health and the integration of hardware and software to support chronic disease management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovation Zed.